|
|
Other links at Articles > Cardiology |
| 3. |
EVA-AMI: Eptifibatide Equal to Abciximab for STEMI Patients Undergoing PCI
|
|
|
The results will be reassuring to cath labs already substituting the cheaper GP IIb/IIIa inhibitor in STEMI patients, but at least one expert believes proof of equivalence for two GP IIb/IIIa inhibitors does not answer the question of whether these agents should be widely in use for STEMI patients. Heartwire
|
| 5. |
BART Closes the Book on Aprotinin
|
|
|
Results from the trial--halted last year due to safety concerns--clearly point to increased deaths in high-risk CABG patients randomized to aprotinin instead of a lysine-analog antifibrinolytic. Heartwire
|
|
|